Technical University of Applied Sciences Wildau

EQS-News: elumeo SE releases 2022 consolidated financial statements: Revenue declines due to Ukraine conflict and inflation - Adjusted EBITDA remains positive - Videoshopping app Jooli continues to g

Retrieved on: 
Friday, April 28, 2023
Virtual reality, University, Marketing, Bank statement, Tax, Gesellschaft mit beschränkter Haftung, EUR, EBITDA, COVID-19, Applied science, Growth, ISIN, SE, Depreciation, Technical University of Applied Sciences Wildau, Laboratory, Bookkeeping, Film industry, Video game

elumeo SE releases 2022 consolidated financial statements: Revenue declines due to Ukraine conflict and inflation - Adjusted EBITDA remains positive - Videoshopping app Jooli continues to g

Key Points: 
  • elumeo SE releases 2022 consolidated financial statements: Revenue declines due to Ukraine conflict and inflation - Adjusted EBITDA remains positive - Videoshopping app Jooli continues to g
    The issuer is solely responsible for the content of this announcement.
  • elumeo SE releases 2022 consolidated financial statements: Revenue declines due to Ukraine conflict and inflation - Adjusted EBITDA remains positive - Videoshopping app Jooli continues to grow rapidly.
  • As a result, the adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also fell lower than the previous year.
  • As a result, elumeo had a positive operating cash flow of EUR 149k in the second half of 2022.

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Retrieved on: 
Thursday, September 16, 2021
Institute of technology, Artificial intelligence, Shoulder, Barrett's esophagus, University, Associate, Technology, Teaching hospital, GI, Applied science, Patient, Colon, University of Oxford, European Society of Neurogastroenterology and Motility, Esophageal cancer, Gastrointestinal Endoscopy, University of Augsburg, Endoscopy, Extrapyramidal system, Dysplasia, Technical University of Applied Sciences Wildau, Esophagus, Google Images, Medical image computing, ESGE, OTH, Gastrointestinal disease, Research, John Radcliffe Hospital, Health, Medical device, Medical imaging

VANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ -- Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable. Barrett's is a gastrointestinal condition affecting around 150 million people globally. Terms of the transaction were not disclosed.

Key Points: 
  • Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable.
  • Satisfai Health's licensing of AI-enhanced software will provide clinicians with faster, more effective diagnostics during endoscopic procedures.
  • Diagnosis entails imaging and biopsies of the esophagus to check for precancerous cells (dysplasia) which can be treated to prevent esophageal cancer.
  • Satisfai Health is a leading medical solutions provider specializing in AI applications for gastroenterology.

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Retrieved on: 
Thursday, September 16, 2021
Institute of technology, Artificial intelligence, Shoulder, Barrett's esophagus, University, Associate, Technology, Teaching hospital, GI, Applied science, Patient, Colon, University of Oxford, European Society of Neurogastroenterology and Motility, Esophageal cancer, Gastrointestinal Endoscopy, University of Augsburg, Endoscopy, Extrapyramidal system, Dysplasia, Technical University of Applied Sciences Wildau, Esophagus, Google Images, Medical image computing, ESGE, OTH, Gastrointestinal disease, Research, John Radcliffe Hospital, Health, Medical device, Medical imaging

VANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ -- Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable. Barrett's is a gastrointestinal condition affecting around 150 million people globally. Terms of the transaction were not disclosed.

Key Points: 
  • Satisfai will further develop AI software that will transform the management of Barrett's Esophagus, critically the detection of early esophageal cancer when curable.
  • Satisfai Health's licensing of AI-enhanced software will provide clinicians with faster, more effective diagnostics during endoscopic procedures.
  • Diagnosis entails imaging and biopsies of the esophagus to check for precancerous cells (dysplasia) which can be treated to prevent esophageal cancer.
  • Satisfai Health is a leading medical solutions provider specializing in AI applications for gastroenterology.